Pure Global

ORTHO - CLINICAL DIAGNOSTICS COLOMBIA S.A.S - Authorized Company ProfileORTHO - CLINICAL DIAGNOSTICS COLOMBIA S.A.S

Explore comprehensive authorized company profile for ORTHO - CLINICAL DIAGNOSTICS COLOMBIA S.A.S through Pure Global AI's free Colombia medical device database. This company manufactures 376 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Jan 11, 2022 to Mar 01, 2034.

This page provides detailed insights including recent registrations, risk class distribution (III: 141, II: 189, IIa: 1, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
376 Devices
5 Risk Classes
ORTHO - CLINICAL DIAGNOSTICS COLOMBIA S.A.S
ORTHO - CLINICAL DIAGNOSTICS COLOMBIA S.A.S
Authorized Company
376
Total Devices
5
Risk Classes
2022
Earliest
2034
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

VITROS CALIBRATOR KIT 27

VITROS CALIBRATOR KIT 27

9f86440e1dbdd034cf1b5df6622039c6

II
Mar 01, 2034

ORTHO ANTIBODY ENHANCEMENT SOLUTION

ORTHO ANTIBODY ENHANCEMENT SOLUTION

c52a35034af310b24c94f544c02112cc

II
Dec 29, 2032

VITROS IMMUNODIAGNOSTIC PRODUCTS FREE PSA REAGENT PACK

VITROS IMMUNODIAGNOSTIC PRODUCTS FREE PSA REAGENT PACK

732d3645480819438290a0d13b605099

II
Oct 03, 2032

1. VITROS CHEMISTRY PRODUCTS A1C SLIDES

1. VITROS CHEMISTRY PRODUCTS A1C SLIDES

f0e190a41255b63010910f1b6b96900a

II
Sep 26, 2032

VITROS CHEMISTRY PRODUCTS PHBR SLIDES

VITROS CHEMISTRY PRODUCTS PHBR SLIDES

d512f35a37119efc3e4aa7aa1bad0649

II
Apr 07, 2032

VITROS TOXOPLASMA IGG

VITROS TOXOPLASMA IGG

539b441d974559a016e56665e571fde9

II
Mar 15, 2031

1. VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK

1. VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK

18fd86fd7248f0b956ccb410236020b9

II
Feb 17, 2031

VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH CALIBRATORS

VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH CALIBRATORS

4856f17efcce8ab77dcf94595be18473

II
Feb 17, 2031

VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH CONTROLS

VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH CONTROLS

816c4928b182aae04ec72427d2d9d52c

II
Feb 17, 2031

1. ORTHO BLISS

1. ORTHO BLISS

40e5e6293d8cc6e7b5a5e705fc1bd97a

II
Dec 17, 2030

1.ORTHO BROMELIN MT6

1.ORTHO BROMELIN MT6

df168fc3bd05e2fa67f761259b1607a1

II
Aug 27, 2029

ORTHO ANTI-K (ANTI-KEL2)

Ortho anti-K (anti-Kel2)

d3f5dbc7d6509d33ec2d8dcff31924cd

III
Aug 27, 2029

VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG

VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG

bf698667df2f55b7fd9b33f755c036c8

III
Jun 14, 2029

ORTHOโ„ข SERA ANTI-D (DVI)

Moneyโ„ข Best Aunt-D (DVI)

787e9cfe543aa5f1082d56ea44b5685a

III
Jun 11, 2029

ORTHOโ„ข SERA ANTI-LEB

Moneyโ„ข is the best anti-lab

bc65e0cdc4e5740b0f90fd65d2dd1b03

III
Jun 11, 2029

ORTHO REAGENT RED BLOOD CELLS 0.8% AFFIRMAGEN

ORTHO REAGENT RED BLOOD CELLS 0.8% AFFIRMAGEN

9caba2685f73b112a08c86afece964a0

III
Jun 11, 2029

ORTHO AFFIRMAGEN 4

ORTHO AFFIRMAGEN 4

c6026e4a1d2d3d2634dd7a331a89dccf

III
Jun 11, 2029

REVERSE DILUENT ORTHO BIOVUE SYSTEM (REVERSE DILUENT CASSETTE)

REVERSE DILUENT ORTHO BIOVUE SYSTEM (REVERSE DILUENT CASSETTE)

f81202df32d88b3f3f475b699691e473

III
Jun 11, 2029

0.8% RESOLVE PANEL B

0.8% RESOLVE PANEL B

489bb5b10344572e6ee8b93326c2436b

III
Jun 11, 2029

BLOOD GROUPING REAGENTS ANTI-A (MONOCLONAL) ANTI-B (MONOCLONAL) ANTI-D (ANTI-D RH1) (MONOCLONAL) CONTROL REVERSE DILUENT ORTHO BIOVUEยฎ SYSTEM (ABO-RH REVERSE GROUPING CASETTE)

BLOOD GROUPING REAGENTS ANTI-A (MONOCLONAL) ANTI-B (MONOCLONAL) ANTI-D (ANTI-D RH1) (MONOCLONAL) CONTROL REVERSE DILUENT ORTHO BIOVUEยฎ SYSTEM (ABO-RH REVERSE GROUPING CASETTE)

2fdc6b439ad9629f1c8e176cc0165679

III
Jun 11, 2029
Risk Class Distribution
Devices by risk class
II
189
50.3% of total
III
141
37.5% of total
Unspecified
42
11.2% of total
I
3
0.8% of total
IIa
1
0.3% of total